Rat Signaling ELISA Kits 2
Rat NOS3/eNOS (Nitric Oxide Synthase 3, Endothelial) CLIA Kit (RTES00200)
- SKU:
- RTES00200
- Product Type:
- ELISA Kit
- ELISA Type:
- CLIA Kit
- Size:
- 96 Assays
- Sensitivity:
- 4.69pg/mL
- Range:
- 7.81-500pg/mL
- ELISA Type:
- Sandwich
- Synonyms:
- ECNOS, NOS III, E-NOS
- Reactivity:
- Rat
- Sample Type:
- Serum, plasma and other biological fluids
Description
Assay type: | Sandwich |
Format: | 96T |
Assay time: | 4.5h |
Reactivity: | Rat |
Detection method: | Chemiluminescence |
Detection range: | 7.81-500 pg/mL |
Sensitivity: | 4.69 pg/mL |
Sample volume: | 100µL |
Sample type: | Serum, plasma and other biological fluids |
Repeatability: | CV < 15% |
Specificity: | This kit recognizes Rat NOS3/eNOS in samples. No significant cross-reactivity or interference between Rat NOS3/eNOS and analogues was observed. |
This kit uses Sandwich-CLIA as the method. The micro CLIA plate provided in this kit has been pre-coated with an antibody specific to Rat NOS3/eNOS. Standards or samples are added to the appropriate micro CLIA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Rat NOS3/eNOS and Avidin-Horseradish Peroxidase (HRP) conjugate are added to each micro plate well successively and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Rat NOS3/eNOS, biotinylated detection antibody and Avidin-HRP conjugate will appear fluorescence. The Relative light unit (RLU) value is measured spectrophotometrically by the Chemiluminescence immunoassay analyzer. The RLU value is positively associated with the concentration of Rat NOS3/eNOS. The concentration of Rat NOS3/eNOS in the samples can be calculated by comparing the RLU of the samples to the standard curve.
UniProt Protein Function: | eNOS: endothelial constitutive nitric oxide synthase. Synthesizes nitric oxide (NO) from arginine and oxygen, which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. Induced in humans by caloric restriction. Stimulated by calcium/calmodulin. Inhibited by NOSIP and NOSTRIN. |
UniProt Protein Details: | Protein type:EC 1. 14. 13. 39; Oxidoreductase; Amino Acid Metabolism - arginine and proline Cellular Component: apical part of cell; caveola; cytoplasm; cytoskeleton; cytosol; Golgi apparatus; lipid raft; mitochondrion; nucleolus; nucleus; plasma membrane; sarcolemma; vesicle membrane Molecular Function:actin binding; actin monomer binding; beta-catenin binding; cadherin binding; calmodulin binding; FAD binding; FMN binding; heme binding; Hsp90 protein binding; iron ion binding; NADP binding; nitric-oxide synthase activity; nitric-oxide synthase binding; protein binding Biological Process: aging; angiogenesis; arginine catabolic process; blood vessel remodeling; endothelial cell migration; female pregnancy; in utero embryonic development; lipopolysaccharide-mediated signaling pathway; lung development; negative regulation of blood pressure; negative regulation of calcium ion transport; negative regulation of cell proliferation; negative regulation of hydrolase activity; negative regulation of muscle hyperplasia; negative regulation of potassium ion transport; negative regulation of smooth muscle cell proliferation; nitric oxide biosynthetic process; nitric oxide mediated signal transduction; ovulation from ovarian follicle; positive regulation of angiogenesis; positive regulation of apoptosis; positive regulation of guanylate cyclase activity; positive regulation of vasodilation; regulation of blood vessel size; regulation of sodium ion transport; regulation of systemic arterial blood pressure by endothelin; regulation of the force of heart contraction by chemical signal; removal of superoxide radicals; response to activity; response to amino acid stimulus; response to axon injury; response to corticosterone stimulus; response to cytokine stimulus; response to drug; response to estradiol stimulus; response to ethanol; response to fructose stimulus; response to hyperoxia; response to hypoxia; response to lead ion; response to lipopolysaccharide; response to lipoprotein stimulus; response to mechanical stimulus; response to metal ion; response to organic cyclic substance; response to peptide hormone stimulus; retina development in camera-type eye; signal transduction; smooth muscle hyperplasia |
NCBI Summary: | enzyme that synthesizes Nitric oxide from L-arginine [RGD, Feb 2006] |
UniProt Code: | Q62600 |
NCBI GenInfo Identifier: | 46402488 |
NCBI Gene ID: | 24600 |
NCBI Accession: | NP_068610. 1 |
UniProt Secondary Accession: | Q62600,O88672, O89041, Q62734, Q68GV6, Q75NE4, |
UniProt Related Accession: | Q62600 |
Molecular Weight: | 133,290 Da |
NCBI Full Name: | nitric oxide synthase, endothelial |
NCBI Synonym Full Names: | nitric oxide synthase 3 |
NCBI Official Symbol: | Nos3 |
NCBI Official Synonym Symbols: | eNos |
NCBI Protein Information: | nitric oxide synthase, endothelial |
UniProt Protein Name: | Nitric oxide synthase, endothelial |
UniProt Synonym Protein Names: | Constitutive NOS; cNOS; EC-NOS; Endothelial NOS; eNOS; NOS type III; NOSIII |
Protein Family: | Nitric oxide synthase |
UniProt Gene Name: | Nos3 |
UniProt Entry Name: | NOS3_RAT |
As the RLU values of the standard curve may vary according to the conditions of the actual assay performance (e. g. operator, pipetting technique, washing technique or temperature effects), the operator should establish a standard curve for each test. Typical standard curve and data is provided below for reference only.
Concentration (pg/mL) | RLU | Average | Corrected |
500 | 48737 54337 | 51537 | 51508 |
250 | 19788 22208 | 20998 | 20969 |
125 | 9889 8903 | 9396 | 9367 |
62.5 | 4391 4633 | 4512 | 4483 |
31.25 | 2331 2267 | 2299 | 2270 |
15.63 | 1296 1204 | 1250 | 1221 |
7.81 | 692 788 | 740 | 711 |
0 | 28 30 | 29 | -- |
Precision
Intra-assay Precision (Precision within an assay): 3 samples with low, mid range and high level Rat NOS3/eNOS were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, mid range and high level Rat NOS3/eNOS were tested on 3 different plates, 20 replicates in each plate.
Intra-assay Precision | Inter-assay Precision | |||||
Sample | 1 | 2 | 3 | 1 | 2 | 3 |
n | 20 | 20 | 20 | 20 | 20 | 20 |
Mean (pg/mL) | 24.14 | 61.40 | 193.55 | 21.99 | 66.12 | 195.86 |
Standard deviation | 2.79 | 5.53 | 14.83 | 2.58 | 5.20 | 13.67 |
C V (%) | 11.56 | 9.01 | 7.66 | 11.73 | 7.86 | 6.98 |
Recovery
The recovery of Rat NOS3/eNOS spiked at three different levels in samples throughout the range of the assay was evaluated in various matrices.
Sample Type | Range (%) | Average Recovery (%) |
Serum (n=5) | 91-103 | 96 |
EDTA plasma (n=5) | 92-105 | 99 |
Cell culture media (n=5) | 93-106 | 99 |
Linearity
Samples were spiked with high concentrations of Rat NOS3/eNOS and diluted with Reference Standard & Sample Diluent to produce samples with values within the range of the assay.
Serum (n=5) | EDTA plasma (n=5) | Cell culture media (n=5) | ||
1:2 | Range (%) | 86-100 | 101-118 | 94-110 |
Average (%) | 91 | 109 | 101 | |
1:4 | Range (%) | 94-109 | 94-109 | 101-116 |
Average (%) | 100 | 101 | 109 | |
1:8 | Range (%) | 101-115 | 99-113 | 91-104 |
Average (%) | 108 | 107 | 97 | |
1:16 | Range (%) | 91-107 | 87-102 | 100-114 |
Average (%) | 98 | 94 | 106 |
An unopened kit can be stored at 4°C for 1 month. If the kit is not used within 1 month, store the items separately according to the following conditions once the kit is received.
Item | Specifications | Storage |
Micro CLIA Plate(Dismountable) | 8 wells ×12 strips | -20°C, 6 months |
Reference Standard | 2 vials | |
Concentrated Biotinylated Detection Ab (100×) | 1 vial, 120 µL | |
Concentrated HRP Conjugate (100×) | 1 vial, 120 µL | -20°C(shading light), 6 months |
Reference Standard & Sample Diluent | 1 vial, 20 mL | 4°C, 6 months |
Biotinylated Detection Ab Diluent | 1 vial, 14 mL | |
HRP Conjugate Diluent | 1 vial, 14 mL | |
Concentrated Wash Buffer (25×) | 1 vial, 30 mL | |
Substrate Reagent A | 1 vial, 5 mL | 4°C (shading light) |
Substrate Reagent B | 1 vial, 5 mL | 4°C (shading light) |
Plate Sealer | 5 pieces | |
Product Description | 1 copy | |
Certificate of Analysis | 1 copy |
- Set standard, test sample and control (zero) wells on the pre-coated plate and record theirpositions. It is recommended to measure each standard and sample in duplicate. Note: addall solutions to the bottom of the plate wells while avoiding contact with the well walls. Ensuresolutions do not foam when adding to the wells.
- Aliquot 100 µL of standard solutions into the standard wells.
- Add 100 µL of Sample / Standard dilution buffer into the control (zero) well.
- Add 100 µL of properly diluted sample (serum, plasma, tissue homogenates and otherbiological fluids. ) into test sample wells.
- Cover the plate with the sealer provided in the kit and incubate for 90 min at 37 °C.
- Aspirate the liquid from each well, do not wash. Immediately add 100 µL of BiotinylatedDetection Ab working solution to each well. Cover the plate with a plate seal and gently mix. Incubate for 1 hour at 37 °C.
- Aspirate or decant the solution from the plate and add 350 µL of wash buffer to each welland incubate for 1-2 minutes at room temperature. Aspirate the solution from each well andclap the plate on absorbent filter paper to dry. Repeat this process 3 times. Note: a microplatewasher can be used in this step and other wash steps.
- Add 100 µL of HRP Conjugate working solution to each well. Cover with a plate seal andincubate for 30 min at 37 °C.
- Aspirate or decant the solution from each well. Repeat the wash process for five times asconducted in step 7.
- Add 100 µL of Substrate mixture solution to each well. Cover with a new plate seal andincubate for no more than 5 min at 37 °C. Protect the plate from light.
- Determine the RLU value of each well immediately.